Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CODX OTCMKTS:ECIA NASDAQ:INBS NASDAQ:OSRH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCODXCo-Diagnostics$0.32+3.9%$0.27$0.23▼$2.23$11.82M0.515.37 million shs1.25 million shsECIAEncision$0.21+0.5%$0.33$0.21▼$0.50$2.50M0.653,441 shs10,100 shsINBSIntelligent Bio Solutions$1.48+0.7%$1.71$1.07▼$3.00$13.20M4.59134,065 shs96,845 shsOSRHOSR$0.52+9.1%$1.01$0.45▼$13.40$10.19M1.49636,340 shs27.20 million shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCODXCo-Diagnostics+3.91%+8.40%+10.61%+37.69%-79.69%ECIAEncision+0.48%-15.60%-42.35%-39.71%-39.71%INBSIntelligent Bio Solutions+0.68%+0.68%-30.19%+4.96%+19.35%OSRHOSR+9.57%-2.74%-49.51%-55.60%+51,499,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCODXCo-Diagnostics4.4422 of 5 stars3.55.00.04.42.00.01.3ECIAEncisionN/AN/AN/AN/AN/AN/AN/AN/AINBSIntelligent Bio Solutions0.3597 of 5 stars0.02.00.00.02.50.00.6OSRHOSRN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCODXCo-Diagnostics 3.00Buy$5.501,624.68% UpsideECIAEncision 0.00N/AN/AN/AINBSIntelligent Bio Solutions 0.00N/AN/AN/AOSRHOSR 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest ECIA, OSRH, CODX, and INBS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/15/2025CODXCo-DiagnosticsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.00(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCODXCo-Diagnostics$3.91M3.14N/AN/A$1.07 per share0.30ECIAEncision$6.55M0.38N/AN/A$0.14 per share1.51INBSIntelligent Bio Solutions$3.05M4.36N/AN/A$0.31 per share4.77OSRHOSRN/AN/AN/AN/A$6.45 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCODXCo-Diagnostics-$37.64M-$1.15N/AN/AN/A-3,588.33%-69.49%-60.49%11/6/2025 (Estimated)ECIAEncision-$220K-$0.02N/A∞N/A-4.34%-16.99%-7.45%N/AINBSIntelligent Bio Solutions-$10.57M-$2.05N/A4.23N/A-346.22%-231.13%-108.24%11/6/2025 (Estimated)OSRHOSR-$2.41MN/A0.00∞N/AN/A-12.19%-8.18%N/ALatest ECIA, OSRH, CODX, and INBS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/15/2025Q4 2025INBSIntelligent Bio Solutions-$0.12-$0.37-$0.25-$0.41$4.30 million$0.84 million8/14/2025Q2 2025CODXCo-Diagnostics-$0.25-$0.23+$0.02-$0.23$0.30 million$0.16 million8/14/2025Q2 2025OSRHOSRN/A$0.02N/A$0.02N/A$1.14 million7/10/2025Q4 2025ECIAEncisionN/A-$0.01N/A-$0.01N/A$1.58 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCODXCo-DiagnosticsN/AN/AN/AN/AN/AECIAEncisionN/AN/AN/AN/AN/AINBSIntelligent Bio SolutionsN/AN/AN/AN/AN/AOSRHOSRN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCODXCo-DiagnosticsN/A4.124.23ECIAEncision0.101.920.72INBSIntelligent Bio SolutionsN/A0.770.97OSRHOSRN/A0.180.20Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCODXCo-Diagnostics14.99%ECIAEncision8.20%INBSIntelligent Bio Solutions32.97%OSRHOSR55.30%Insider OwnershipCompanyInsider OwnershipCODXCo-Diagnostics8.40%ECIAEncision36.75%INBSIntelligent Bio Solutions1.54%OSRHOSR33.67%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCODXCo-Diagnostics10038.52 million35.29 millionOptionableECIAEncision3011.88 million7.51 millionNot OptionableINBSIntelligent Bio Solutions108.98 million8.84 millionNot OptionableOSRHOSRN/A21.58 million14.32 millionN/AECIA, OSRH, CODX, and INBS HeadlinesRecent News About These CompaniesOSR Holdings Amends Note Purchase AgreementAugust 20 at 5:51 PM | tipranks.comLatest OSR Holdings Stock News | NASDAQ:OSRH | BenzingaAugust 9, 2025 | benzinga.comOSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025August 1, 2025 | prnewswire.comOSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share ...August 1, 2025 | morningstar.comMOSR Holdings Inc.: OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange StructureAugust 1, 2025 | finanznachrichten.deOSR Holdings Reveals Update on Woori IO Deal and Share ExchangeAugust 1, 2025 | msn.comOSR Holdings Provides Transparency Update on Equity Financing InstrumentsJuly 31, 2025 | prnewswire.comOSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange StructureJuly 30, 2025 | prnewswire.comOSR Holdings to acquire South Korea’s medical device company Woori IOJuly 28, 2025 | finance.yahoo.comOSR Holdings enters term sheet to acquire Woori IO (OSRH:NASDAQ)July 25, 2025 | seekingalpha.comOSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in ...July 25, 2025 | seekingalpha.comOSR Holdings signs term sheet to acquire noninvasive glucose tech firmJuly 25, 2025 | investing.comOSR Holdings signs term sheet to acquire South Korea-based noninvasive glucose monitoring technology company, Woori IOJuly 25, 2025 | pharmabiz.comPOSR Holdings enters term sheet to acquire Woori IOJuly 24, 2025 | msn.comOSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring TechnologyJuly 24, 2025 | prnewswire.comOSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR CompanyJuly 15, 2025 | prnewswire.comOSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D ...July 11, 2025 | taiwannews.com.twTOSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG | MorningstarJuly 9, 2025 | morningstar.comMOSR Holdings plans $50 million security token offering in 2025July 9, 2025 | uk.investing.comOSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AGJuly 9, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 2025These 3 Stocks Could Help You Compound Wealth for Years to ComeBy Gabriel Osorio-Mazilli | July 28, 2025Qualcomm's Next Gear: A Growth Story Wall Street Might Be MissingBy Jeffrey Neal Johnson | July 25, 2025Why BigBear.ai Stock's Dip on Earnings Can Be an Opportunity By Gabriel Osorio-Mazilli | August 13, 2025Traders Turn Bullish on Housing Stocks Again—3 Leading the WayBy Gabriel Osorio-Mazilli | August 4, 2025ECIA, OSRH, CODX, and INBS Company DescriptionsCo-Diagnostics NASDAQ:CODX$0.32 +0.01 (+3.91%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$0.31 0.00 (-1.54%) As of 08/22/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.Encision OTCMKTS:ECIA$0.21 +0.00 (+0.48%) As of 08/22/2025 03:57 PM EasternEncision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.Intelligent Bio Solutions NASDAQ:INBS$1.48 +0.01 (+0.68%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$1.48 +0.01 (+0.34%) As of 08/22/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.OSR NASDAQ:OSRH$0.52 +0.04 (+9.09%) As of 08/22/2025 03:59 PM EasternOSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet’s Breakout Potential: From Laggard to AI Leader After Earnings Miss, Walmart Is Still a Top Consumer Staples Play Should You Join Buffett and Invest in Constellation Brands? Can Identity Security Fuel CrowdStrike’s Next Growth Phase? 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Shopify’s Risk-Reward Profile Is Suddenly Red Hot 3 Reasons Salesforce Is a Bargain Right Now Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access